Cargando…
Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second‐line chemotherapy
INTRODUCTION: Adrenocortical carcinoma is a rare malignant tumor with an unfavorable prognosis in the advanced stage for which second‐/third‐line chemotherapy is not well established. CASE PRESENTATION: A 34‐year‐old woman was referred to our institution for left adrenal tumor with multiple liver me...
Autores principales: | Yamamoto, Akinaru, Nakai, Yasutomo, Oka, Toshiki, Kanaki, Tomohiro, Yamamoto, Yoshiyuki, Nagahara, Akira, Nakayama, Masashi, Kakimoto, Ken‐ichi, Nishimura, Kazuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609173/ https://www.ncbi.nlm.nih.gov/pubmed/33163922 http://dx.doi.org/10.1002/iju5.12214 |
Ejemplares similares
-
Renal cell carcinoma with central nervous system demyelination caused by nivolumab
por: Oka, Toshiki, et al.
Publicado: (2020) -
Two cases of delayed onset of immune‐related adverse events after discontinuation of nivolumab in patients with metastatic renal cell cancer
por: Nakai, Yasutomo, et al.
Publicado: (2021) -
Editorial Comment to Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second‐line chemotherapy
por: Kandori, Shuya
Publicado: (2020) -
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy
por: Grisanti, Salvatore, et al.
Publicado: (2021) -
Partial nephrectomy for a Bosniak IV cystic renal mass mimicking a simple renal cyst adjacent to a solid renal tumor
por: Oka, Toshiki, et al.
Publicado: (2020)